NFKB1 and cervical cancer: By using a non-replicative virus, we observed a 2- to 10-fold increase in promoter activity under hypoxia and TNFα (as an activator of the NFkB elements of the promoter [19]) in human cervical cancer cell lines (Figure 1A).